SARS-CoV-2 tagged posts

Durable, Washable Textile Coating can Repel Viruses

An illustration shows the treated textile’s ability to repel fluids.

New research could lead to safely reusable PPE. Researchers have created a textile coating that can not only repel liquids like blood and saliva but can also prevent viruses from adhering to the surface. Masks, gowns, and other personal protective equipment (PPE) are essential for protecting healthcare workers. However, the textiles and materials used in such items can absorb and carry viruses and bacteria, inadvertently spreading the disease the wearer sought to contain.

When the coronavirus spread amongst healthcare professionals and left PPE in short supply, finding a way to provide better protection while allowing for the safe reuse of these items became paramount.

Research from the LAMP Lab at the Universit...

Read More

Imaging reveals Bowel Abnormalities in Patients with COVID-19

Coronal CT of the abdomen and pelvis with IV contrast in a 47-year-old man with abdominal tenderness demonstrates typical findings of mesenteric ischemia and infarction, including pneumatosis intestinalis (arrow) and non-enhancing bowel (*). Frank discontinuity of a thickened loop of small bowel in the pelvis (thin arrow) is in keeping with perforation.

Patients with COVID-19 can have bowel abnormalities, including ischemia, according to a new study published recently in the journal Radiology.

Several studies have evaluated the chest imaging findings in COVID-19, which helped improve understanding of how the disease affects the lungs. More recently, reports have documented that gastrointestinal symptoms, liver injury, and vascular findings are common in these patients...

Read More

Diagnostic Biosensor quickly detects SARS-CoV-2 from Nasopharyngeal Swabs

An artist’s rendering above shows a new test that quickly detects SARS-CoV-2 (spheres) through binding to antibodies (Y-shapes) on a field-effect transistor.
Adapted from ACS Nano 2020, DOI: 10.1021/acsnano.0c02823

Researchers have developed a field-effect transistor-based biosensor that detects SARS-CoV-2 in nasopharyngeal swabs from patients with COVID-19, in less than one minute.

According to many experts, early diagnosis and management are critical for slowing the spread of SARS-CoV-2, the new coronavirus that causes COVID-19. Therefore, the race is on to develop diagnostic tests for the virus that are faster, easier and more accurate than existing ones...

Read More

Trial Drug can significantly Block Early stages of COVID-19 in engineered human tissues

In cell cultures analyzed in the current study, hrsACE2 inhibited the coronavirus load by a factor of 1,000-5,000. Credit: IMBA/Tibor Kulcsar

An international team led by University of British Columbia researcher Dr. Josef Penninger has found a trial drug that effectively blocks the cellular door SARS-CoV-2 uses to infect its hosts.

The findings, published today in Cell, hold promise as a treatment capable of stopping early infection of the novel coronavirus that, as of April 2, has affected more than 981,000 people and claimed the lives of 50,000 people worldwide.

The study provides new insights into key aspects of SARS-CoV-2, the virus that causes COVID-19, and its interactions on a cellular level, as well as how the virus can infect blood vessels and kidneys.

“We are hopefu...

Read More